Investig Clin Urol.  2019 Jul;60(4):258-266. 10.4111/icu.2019.60.4.258.

Dynamic thiol/disulfide homeostasis as a novel indicator of oxidative stress in patients with urolithiasis

Affiliations
  • 1Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey. drgiraysonmez@gmail.com
  • 2Department of Anesthesiology and Reanimation, University of Health Sciences, Konya Training and Research Hospital, Konya, Turkey.
  • 3Department of Medical Biochemistry, University of Health Sciences, Konya Training and Research Hospital, Konya, Turkey.
  • 4Department of Medical Education and Informatics, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.
  • 5Department of Biochemistry, Yildirim Beyazit University, School of Medicine, Ankara Ataturk Teaching and Research Hospital, Ankara, Turkey.

Abstract

PURPOSE
A dynamic thiol/disulfide balance is pivotal in organizing anti-oxidant defense, detoxification, apoptosis, and enzyme activities, as well as transcription and cellular signal-transfer mechanisms. The connection between urolithiasis and oxidant/antioxidant status, which can be assessed through thiol-disulfide homeostasis (TDH), has not yet been examined. In this study, we evaluated the effects of TDH on the formation, size, and location of stones by examining the associations between TDH parameters and urolithiasis.
MATERIALS AND METHODS
Patients with urolithiasis and healthy controls were recruited. The patients were divided into subgroups in terms of stone size (>15 mm or ≤15 mm) and stone location (nephrolithiasis or ureterolithiasis). TDH parameters were measured using a novel automatic and spectrophotometric method and compared statistically.
RESULTS
TDH parameters were different between the urolithiasis and control groups. TDH tended towards the disulfide side in the urolithiasis group. Stone size increased an average 0.14 mm with a 1 µmol/L increase in disulfide level and decreased an average 0.058 mm with a 1 µmol/L increase in native thiol level. Disulfide and native thiol levels were found to be different across patients with stone size >15 mm, ≤15 mm, and controls (p<0.001 and p<0.001, respectively). However, the nephrolithiasis and ureterolithiasis groups were similar in respect of TDH parameters.
CONCLUSIONS
In this study, it was found that patients with urolithiasis displayed oxidative stress characterized by a TDH tendency towards the disulfide side, and an inadequate antioxidant response identified by a lower level of native thiol as compared with healthy controls.

Keyword

Antioxidants; Disulfides; Homeostasis; Oxidative stress; Urolithiasis

MeSH Terms

Antioxidants
Apoptosis
Disulfides
Homeostasis*
Humans
Methods
Nephrolithiasis
Oxidative Stress*
Ureterolithiasis
Urolithiasis*
Antioxidants
Disulfides

Figure

  • Fig. 1 Disulfide levels of stone size subgroup.

  • Fig. 2 Native thiol levels of stone size subgroup.


Reference

1. Türk C, Neisius A, Petrik A, Seitz C, Skolarikos A, Tepeler A, et al. European Association of Urology guidelines on urolithiasis [Internet]. Arnhem: The European Association of Urology;2017. 3. cited 2019 Jan. Available from: https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urolithiasis_2017_10-05V2.pdf.
2. Yasui T, Okada A, Hamamoto S, Ando R, Taguchi K, Tozawa K, et al. Pathophysiology-based treatment of urolithiasis. Int J Urol. 2017; 24:32–38. PMID: 27539983.
Article
3. Kaya E, Ebiloğlu T, Zor M, Yalççn S, Coğuplugil AE, Bedir S. The outcome of percutaneous nephrolithotomy on ≥50 mm staghorn and multiple calyceal stones. Turk J Urol. 2018; 44:148–152. PMID: 29511585.
Article
4. Noureldin YA, da Silva A, Fahmy N, Andonian S. Is it safe to prescribe ascorbic acid for urinary acidification in stone-forming patients with alkaline urine? Turk J Urol. 2017; 43:183–188. PMID: 28717544.
Article
5. Ceban E, Banov P, Galescu A, Botnari V. Oxidative stress and antioxidant status in patients with complicated urolithiasis. J Med Life. 2016; 9:259–262. PMID: 27974930.
6. Ma MC, Chen YS, Huang HS. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage. Urology. 2014; 83:510.e9–510.e17.
Article
7. Engin A, Altan N. Effects of obstructive jaundice on the antioxidative capacity of human red blood cells. Haematologia (Budap). 2000; 30:91–96. PMID: 10839561.
Article
8. Yardim-Akaydin S, Sepici A, Ozkan Y, Torun M, Simşek B, Sepici V. Oxidation of uric acid in rheumatoid arthritis: is allantoin a marker of oxidative stress. Free Radic Res. 2004; 38:623–628. PMID: 15346653.
Article
9. Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res. 2001; 477:7–21. PMID: 11376682.
Article
10. Cremers CM, Jakob U. Oxidant sensing by reversible disulfide bond formation. J Biol Chem. 2013; 288:26489–26496. PMID: 23861395.
Article
11. Sen CK, Packer L. Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr. 2000; 72(2 Suppl):653S–669S. PMID: 10919972.
Article
12. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014; 47:326–332. PMID: 25304913.
Article
13. Altıparmak IH, Erkuş ME, Sezen H, Demirbag R, Gunebakmaz O, Kaya Z, et al. The relation of serum thiol levels and thiol/disulphide homeostasis with the severity of coronary artery disease. Kardiol Pol. 2016; 74:1346–1353. PMID: 27221962.
Article
14. Ates I, Kaplan M, Yuksel M, Mese D, Alisik M, Erel Ö, et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine. 2016; 51:47–51. PMID: 26547218.
Article
15. Dirican N, Dirican A, Sen O, Aynali A, Atalay S, Bircan HA, et al. Thiol/disulfide homeostasis: a prognostic biomarker for patients with advanced non-small cell lung cancer? Redox Rep. 2016; 21:197–203. PMID: 26200761.
Article
16. Göknar N, Oktem F, Arı E, Demir AD, Torun E. Is oxidative stress related to childhood urolithiasis? Pediatr Nephrol. 2014; 29:1381–1386. PMID: 24526098.
Article
17. Khan SR. Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res. 2006; 34:86–91. PMID: 16404622.
Article
18. Khan SR. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res. 2012; 40:95–112. PMID: 22213019.
Article
19. Fishman AI, Green D, Lynch A, Choudhury M, Eshghi M, Konno S. Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation. Urology. 2013; 82:489.e1–489.e7.
Article
20. Yücel D. C-Reactive protein vs. high-sensitivity C-reactive protein: what is the difference? Turk J Biochem. 2014; 39:43–44.
21. Seropian IM, Romeo FJ, Pizarro R, Vulcano NO, Posatini RA, Marenchino RG, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of survival after heart transplantation. ESC Heart Fail. 2018; 5:149–156. PMID: 28758719.
Article
22. Hirose M, Yasui T, Okada A, Hamamoto S, Shimizu H, Itoh Y, et al. Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. Int J Urol. 2010; 17:83–92. PMID: 19919640.
Article
23. Hirose M, Tozawa K, Okada A, Hamamoto S, Higashibata Y, Gao B, et al. Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice. Urol Res. 2012; 40:121–129. PMID: 21833789.
Article
24. Grases F, Costa-Bauzá A, Bonarriba CR, Pieras EC, Fernández RA, Rodríguez A. On the origin of calcium oxalate monohydrate papillary renal stones. Urolithiasis. 2015; 43(Suppl 1):33–39. PMID: 25086903.
Article
25. Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol. 2005; 173:271–275. PMID: 15592095.
Article
26. Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. Examination of the anti-oxidative effect in renal tubular cells and apoptosis by oxidative stress. Urol Res. 2005; 33:261–266. PMID: 16047215.
Article
27. Bal C, Büyükşekerci M, Koca C, AXğış ER, Erdoğan S, Baran P, et al. The compromise of dynamic disulfide/thiol homeostasis as a biomarker of oxidative stress in trichloroethylene exposure. Hum Exp Toxicol. 2016; 35:915–920. PMID: 26429930.
Article
28. Emre S, Demirseren DD, Alisik M, Aktas A, Neselioglu S, Erel O. Dynamic thiol/disulfide homeostasis and effects of smoking on homeostasis parameters in patients with psoriasis. Cutan Ocul Toxicol. 2017; 36:393–396. PMID: 28397526.
Article
29. Demirseren DD, Cicek C, Alisik M, Demirseren ME, Aktaş A, Erel O. Dynamic thiol/disulphide homeostasis in patients with basal cell carcinoma. Cutan Ocul Toxicol. 2017; 36:278–282. PMID: 28067074.
Article
30. Hanikoglu F, Hanikoglu A, Kucuksayan E, Alisik M, Gocener AA, Erel O, et al. Dynamic thiol/disulphide homeostasis before and after radical prostatectomy in patients with prostate cancer. Free Radic Res. 2016; 50:S79–S84. PMID: 27620702.
Article
Full Text Links
  • ICU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr